418 related articles for article (PubMed ID: 21496237)
1. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
Alhosin M; Sharif T; Mousli M; Etienne-Selloum N; Fuhrmann G; Schini-Kerth VB; Bronner C
J Exp Clin Cancer Res; 2011 Apr; 30(1):41. PubMed ID: 21496237
[TBL] [Abstract][Full Text] [Related]
2. Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.
Alhosin M; Omran Z; Zamzami MA; Al-Malki AL; Choudhry H; Mousli M; Bronner C
J Exp Clin Cancer Res; 2016 Nov; 35(1):174. PubMed ID: 27839516
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.
Abdullah O; Omran Z; Hosawi S; Hamiche A; Bronner C; Alhosin M
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922029
[TBL] [Abstract][Full Text] [Related]
4. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.
Unoki M; Brunet J; Mousli M
Biochem Pharmacol; 2009 Nov; 78(10):1279-88. PubMed ID: 19501055
[TBL] [Abstract][Full Text] [Related]
5. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1.
Achour M; Mousli M; Alhosin M; Ibrahim A; Peluso J; Muller CD; Schini-Kerth VB; Hamiche A; Dhe-Paganon S; Bronner C
Biochem Biophys Res Commun; 2013 Jan; 430(1):208-12. PubMed ID: 23201574
[TBL] [Abstract][Full Text] [Related]
7. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
8. Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis.
Bronner C; Krifa M; Mousli M
Biochem Pharmacol; 2013 Dec; 86(12):1643-9. PubMed ID: 24134914
[TBL] [Abstract][Full Text] [Related]
9. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
[TBL] [Abstract][Full Text] [Related]
10. The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation.
Vaughan RM; Rothbart SB; Dickson BM
J Biol Chem; 2019 Oct; 294(43):15724-15732. PubMed ID: 31481468
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
12. UHRF1 poly-auto-ubiquitination induced by the anti-cancer drug, thymoquinone, is involved in the DNA repair machinery recruitment.
Almalki NAR; Sabir JSM; Ibrahim A; Alhosin M; Asseri AH; Albiheyri RS; Zari AT; Bahieldin A; Javed A; Mély Y; Hamiche A; Mousli M; Bronner C
Int J Biochem Cell Biol; 2024 Jun; 171():106582. PubMed ID: 38649007
[TBL] [Abstract][Full Text] [Related]
13. Structure-based screening of chemical libraries to identify small molecules that are likely to bind with the SET and RING-associated (SRA) domain of Ubiquitin-like, PHD and Ring Finger-containing 1 (UHRF1).
Patnaik D
BMC Res Notes; 2020 May; 13(1):254. PubMed ID: 32448288
[TBL] [Abstract][Full Text] [Related]
14. The histone and non-histone methyllysine reader activities of the UHRF1 tandem Tudor domain are dispensable for the propagation of aberrant DNA methylation patterning in cancer cells.
Vaughan RM; Kupai A; Foley CA; Sagum CA; Tibben BM; Eden HE; Tiedemann RL; Berryhill CA; Patel V; Shaw KM; Krajewski K; Strahl BD; Bedford MT; Frye SV; Dickson BM; Rothbart SB
Epigenetics Chromatin; 2020 Oct; 13(1):44. PubMed ID: 33097091
[TBL] [Abstract][Full Text] [Related]
15. UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity.
Achour M; Fuhrmann G; Alhosin M; Rondé P; Chataigneau T; Mousli M; Schini-Kerth VB; Bronner C
Biochem Biophys Res Commun; 2009 Dec; 390(3):523-8. PubMed ID: 19800870
[TBL] [Abstract][Full Text] [Related]
16. Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.
Choudhry H; Zamzami MA; Omran Z; Wu W; Mousli M; Bronner C; Alhosin M
Oncol Lett; 2018 Jan; 15(1):3-10. PubMed ID: 29285183
[TBL] [Abstract][Full Text] [Related]
17. [Role of UHRF1 in methylation regulation and angiogenesis].
Guo Z; Mo Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):200-204. PubMed ID: 32034755
[TBL] [Abstract][Full Text] [Related]
18. UHRF1, a modular multi-domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications.
Hashimoto H; Horton JR; Zhang X; Cheng X
Epigenetics; 2009 Jan; 4(1):8-14. PubMed ID: 19077538
[TBL] [Abstract][Full Text] [Related]
19. Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1.
Ashraf W; Ahmad T; Reynoird N; Hamiche A; Mély Y; Bronner C; Mousli M
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630248
[TBL] [Abstract][Full Text] [Related]
20. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?
Bronner C; Achour M; Arima Y; Chataigneau T; Saya H; Schini-Kerth VB
Pharmacol Ther; 2007 Sep; 115(3):419-34. PubMed ID: 17658611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
